combination therapy of propranolol and laser against infantile hemangioma

combination therapy of propranolol and laser against infantile hemangioma - combination therapy of propranolol and laser against infantile hemangioma

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031522

Enrollment

Registered

2018-04-01

Start date

2018-04-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infantile hemangioma

Interventions

combination

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: cardiovascular abnormality

Design outcomes

Primary

Measure	Time frame
efficacy at 24 weeks	—

Countries

Japan

Contacts

Public ContactMasatoshi Jinnin

Wakayama Medical University Department of Dermatology

mjin@wakayama-med.ac.jp0734472300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026